Drug Type T-lymphocyte cell therapy |
Synonyms- |
Target- |
Mechanism Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Kairos Pharma Ltd.Startup |
Active Organization Kairos Pharma Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | US | Kairos Pharma Ltd.Startup | - |